These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 27474071)

  • 1. Bimodal Expansion of the Lymphatic Vessels Is Regulated by the Sequential Expression of IL-7 and Lymphotoxin α1β2 in Newly Formed Tertiary Lymphoid Structures.
    Nayar S; Campos J; Chung MM; Navarro-Núñez L; Chachlani M; Steinthal N; Gardner DH; Rankin P; Cloake T; Caamaño JH; McGettrick HM; Watson SP; Luther S; Buckley CD; Barone F
    J Immunol; 2016 Sep; 197(5):1957-67. PubMed ID: 27474071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of core TNF/LIGHT family members in lymph node homeostasis and remodeling.
    Zhu M; Fu YX
    Immunol Rev; 2011 Nov; 244(1):75-84. PubMed ID: 22017432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphotoxin-alpha 1 beta 2 and LIGHT induce classical and noncanonical NF-kappa B-dependent proinflammatory gene expression in vascular endothelial cells.
    Madge LA; Kluger MS; Orange JS; May MJ
    J Immunol; 2008 Mar; 180(5):3467-77. PubMed ID: 18292573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dimerization of LTβR by LTα1β2 is necessary and sufficient for signal transduction.
    Sudhamsu J; Yin J; Chiang EY; Starovasnik MA; Grogan JL; Hymowitz SG
    Proc Natl Acad Sci U S A; 2013 Dec; 110(49):19896-901. PubMed ID: 24248355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treg engage lymphotoxin beta receptor for afferent lymphatic transendothelial migration.
    Brinkman CC; Iwami D; Hritzo MK; Xiong Y; Ahmad S; Simon T; Hippen KL; Blazar BR; Bromberg JS
    Nat Commun; 2016 Jun; 7():12021. PubMed ID: 27323847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type 3 innate lymphoid cell-derived lymphotoxin prevents microbiota-dependent inflammation.
    Zhang Y; Kim TJ; Wroblewska JA; Tesic V; Upadhyay V; Weichselbaum RR; Tumanov AV; Tang H; Guo X; Tang H; Fu YX
    Cell Mol Immunol; 2018 Jul; 15(7):697-709. PubMed ID: 28579615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global lymphoid tissue remodeling during a viral infection is orchestrated by a B cell-lymphotoxin-dependent pathway.
    Kumar V; Scandella E; Danuser R; Onder L; Nitschké M; Fukui Y; Halin C; Ludewig B; Stein JV
    Blood; 2010 Jun; 115(23):4725-33. PubMed ID: 20185585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B Cell-Activating Factor Promotes B Cell Survival in Ectopic Lymphoid Tissues in Nasal Polyps.
    Wang ZZ; Song J; Wang H; Li JX; Xiao Q; Yu Z; Liu JX; Liu Z
    Front Immunol; 2020; 11():625630. PubMed ID: 33552090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular and Vascular Components of Tertiary Lymphoid Structures.
    Mueller CG; Nayar S; Gardner D; Barone F
    Methods Mol Biol; 2018; 1845():17-30. PubMed ID: 30141005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphotoxin beta receptor signaling is required for inflammatory lymphangiogenesis in the thyroid.
    Furtado GC; Marinkovic T; Martin AP; Garin A; Hoch B; Hubner W; Chen BK; Genden E; Skobe M; Lira SA
    Proc Natl Acad Sci U S A; 2007 Mar; 104(12):5026-31. PubMed ID: 17360402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human CD4+CD3- innate-like T cells provide a source of TNF and lymphotoxin-αβ and are elevated in rheumatoid arthritis.
    Bekiaris V; Šedy JR; Rossetti M; Spreafico R; Sharma S; Rhode-Kurnow A; Ware BC; Huang N; Macauley MG; Norris PS; Albani S; Ware CF
    J Immunol; 2013 Nov; 191(9):4611-8. PubMed ID: 24078690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune mechanisms orchestrate tertiary lymphoid structures in tumors via cancer-associated fibroblasts.
    Rodriguez AB; Peske JD; Woods AN; Leick KM; Mauldin IS; Meneveau MO; Young SJ; Lindsay RS; Melssen MM; Cyranowski S; Parriott G; Conaway MR; Fu YX; Slingluff CL; Engelhard VH
    Cell Rep; 2021 Jul; 36(3):109422. PubMed ID: 34289373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunofibroblasts are pivotal drivers of tertiary lymphoid structure formation and local pathology.
    Nayar S; Campos J; Smith CG; Iannizzotto V; Gardner DH; Mourcin F; Roulois D; Turner J; Sylvestre M; Asam S; Glaysher B; Bowman SJ; Fearon DT; Filer A; Tarte K; Luther SA; Fisher BA; Buckley CD; Coles MC; Barone F
    Proc Natl Acad Sci U S A; 2019 Jul; 116(27):13490-13497. PubMed ID: 31213547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphotoxin-alpha contributes to lymphangiogenesis.
    Mounzer RH; Svendsen OS; Baluk P; Bergman CM; Padera TP; Wiig H; Jain RK; McDonald DM; Ruddle NH
    Blood; 2010 Sep; 116(12):2173-82. PubMed ID: 20566898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of lymphotoxin-beta receptor signaling reduces aspects of Sjögren's syndrome in salivary glands of non-obese diabetic mice.
    Gatumu MK; Skarstein K; Papandile A; Browning JL; Fava RA; Bolstad AI
    Arthritis Res Ther; 2009; 11(1):R24. PubMed ID: 19222863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biology and signal transduction pathways of the Lymphotoxin-αβ/LTβR system.
    Remouchamps C; Boutaffala L; Ganeff C; Dejardin E
    Cytokine Growth Factor Rev; 2011; 22(5-6):301-10. PubMed ID: 22152226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Langerhans Cells Control Lymphatic Vessel Function during Inflammation via LIGHT-LTβR Signaling.
    Wang Z; Wang W; Chai Q; Zhu M
    J Immunol; 2019 May; 202(10):2999-3007. PubMed ID: 30952816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STINGing the Tumor Microenvironment to Promote Therapeutic Tertiary Lymphoid Structure Development.
    Filderman JN; Appleman M; Chelvanambi M; Taylor JL; Storkus WJ
    Front Immunol; 2021; 12():690105. PubMed ID: 34054879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A critical role for dendritic cells in the formation of lymphatic vessels within tertiary lymphoid structures.
    Muniz LR; Pacer ME; Lira SA; Furtado GC
    J Immunol; 2011 Jul; 187(2):828-34. PubMed ID: 21666055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphotoxin signalling in tertiary lymphoid structures and immunotherapy.
    Tang H; Zhu M; Qiao J; Fu YX
    Cell Mol Immunol; 2017 Oct; 14(10):809-818. PubMed ID: 28413217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.